0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Nasal Administration - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-12L16880
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Nasal Administration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BUY CHAPTERS

Nasal Administration - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-12L16880
Report
October 2024
Pages:139
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nasal Administration - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Nasal Administration - Market

Nasal Administration - Market

The global market for Nasal Administration was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nasal Administration, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nasal Administration by region & country, by Type, and by Application.
The Nasal Administration market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Administration.
Market Segmentation

Scope of Nasal Administration - Market Report

Report Metric Details
Report Name Nasal Administration - Market
CAGR 5%
Segment by Type:
  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Atomizer
Segment by Application
  • Hospital
  • Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Consort Medicalplc., AptarGroup,Inc., Vectura Groupplc, 3M, H&T Presspart Manufacturing Ltd., Nemera, GOFIRE INC., Teva Pharmaceutical Industries Lto., Recipharm, Aptar, Catalent, Intertek, MedPharm, ONdrugDelivery, Optinose
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Nasal Administration manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Nasal Administration in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Nasal Administration in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Nasal Administration - Market report?

Ans: The main players in the Nasal Administration - Market are Consort Medicalplc., AptarGroup,Inc., Vectura Groupplc, 3M, H&T Presspart Manufacturing Ltd., Nemera, GOFIRE INC., Teva Pharmaceutical Industries Lto., Recipharm, Aptar, Catalent, Intertek, MedPharm, ONdrugDelivery, Optinose

What are the Application segmentation covered in the Nasal Administration - Market report?

Ans: The Applications covered in the Nasal Administration - Market report are Hospital, Clinic

What are the Type segmentation covered in the Nasal Administration - Market report?

Ans: The Types covered in the Nasal Administration - Market report are Dry Powder Inhaler, Metered Dose Inhaler, Atomizer

1 Market Overview
1.1 Nasal Administration Product Introduction
1.2 Global Nasal Administration Market Size Forecast
1.2.1 Global Nasal Administration Sales Value (2019-2030)
1.2.2 Global Nasal Administration Sales Volume (2019-2030)
1.2.3 Global Nasal Administration Sales Price (2019-2030)
1.3 Nasal Administration Market Trends & Drivers
1.3.1 Nasal Administration Industry Trends
1.3.2 Nasal Administration Market Drivers & Opportunity
1.3.3 Nasal Administration Market Challenges
1.3.4 Nasal Administration Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nasal Administration Players Revenue Ranking (2023)
2.2 Global Nasal Administration Revenue by Company (2019-2024)
2.3 Global Nasal Administration Players Sales Volume Ranking (2023)
2.4 Global Nasal Administration Sales Volume by Company Players (2019-2024)
2.5 Global Nasal Administration Average Price by Company (2019-2024)
2.6 Key Manufacturers Nasal Administration Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Nasal Administration Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nasal Administration
2.9 Nasal Administration Market Competitive Analysis
2.9.1 Nasal Administration Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Nasal Administration Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Administration as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Dry Powder Inhaler
3.1.2 Metered Dose Inhaler
3.1.3 Atomizer
3.2 Global Nasal Administration Sales Value by Type
3.2.1 Global Nasal Administration Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nasal Administration Sales Value, by Type (2019-2030)
3.2.3 Global Nasal Administration Sales Value, by Type (%) (2019-2030)
3.3 Global Nasal Administration Sales Volume by Type
3.3.1 Global Nasal Administration Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Nasal Administration Sales Volume, by Type (2019-2030)
3.3.3 Global Nasal Administration Sales Volume, by Type (%) (2019-2030)
3.4 Global Nasal Administration Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Nasal Administration Sales Value by Application
4.2.1 Global Nasal Administration Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nasal Administration Sales Value, by Application (2019-2030)
4.2.3 Global Nasal Administration Sales Value, by Application (%) (2019-2030)
4.3 Global Nasal Administration Sales Volume by Application
4.3.1 Global Nasal Administration Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Nasal Administration Sales Volume, by Application (2019-2030)
4.3.3 Global Nasal Administration Sales Volume, by Application (%) (2019-2030)
4.4 Global Nasal Administration Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Nasal Administration Sales Value by Region
5.1.1 Global Nasal Administration Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nasal Administration Sales Value by Region (2019-2024)
5.1.3 Global Nasal Administration Sales Value by Region (2025-2030)
5.1.4 Global Nasal Administration Sales Value by Region (%), (2019-2030)
5.2 Global Nasal Administration Sales Volume by Region
5.2.1 Global Nasal Administration Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Nasal Administration Sales Volume by Region (2019-2024)
5.2.3 Global Nasal Administration Sales Volume by Region (2025-2030)
5.2.4 Global Nasal Administration Sales Volume by Region (%), (2019-2030)
5.3 Global Nasal Administration Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Nasal Administration Sales Value, 2019-2030
5.4.2 North America Nasal Administration Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Nasal Administration Sales Value, 2019-2030
5.5.2 Europe Nasal Administration Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Nasal Administration Sales Value, 2019-2030
5.6.2 Asia Pacific Nasal Administration Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Nasal Administration Sales Value, 2019-2030
5.7.2 South America Nasal Administration Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nasal Administration Sales Value, 2019-2030
5.8.2 Middle East & Africa Nasal Administration Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nasal Administration Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nasal Administration Sales Value
6.2.1 Key Countries/Regions Nasal Administration Sales Value, 2019-2030
6.2.2 Key Countries/Regions Nasal Administration Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Nasal Administration Sales Value, 2019-2030
6.3.2 United States Nasal Administration Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nasal Administration Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nasal Administration Sales Value, 2019-2030
6.4.2 Europe Nasal Administration Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nasal Administration Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nasal Administration Sales Value, 2019-2030
6.5.2 China Nasal Administration Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nasal Administration Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nasal Administration Sales Value, 2019-2030
6.6.2 Japan Nasal Administration Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nasal Administration Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nasal Administration Sales Value, 2019-2030
6.7.2 South Korea Nasal Administration Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nasal Administration Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nasal Administration Sales Value, 2019-2030
6.8.2 Southeast Asia Nasal Administration Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nasal Administration Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nasal Administration Sales Value, 2019-2030
6.9.2 India Nasal Administration Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nasal Administration Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Consort Medicalplc.
7.1.1 Consort Medicalplc. Company Information
7.1.2 Consort Medicalplc. Introduction and Business Overview
7.1.3 Consort Medicalplc. Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Consort Medicalplc. Nasal Administration Product Offerings
7.1.5 Consort Medicalplc. Recent Development
7.2 AptarGroup,Inc.
7.2.1 AptarGroup,Inc. Company Information
7.2.2 AptarGroup,Inc. Introduction and Business Overview
7.2.3 AptarGroup,Inc. Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.2.4 AptarGroup,Inc. Nasal Administration Product Offerings
7.2.5 AptarGroup,Inc. Recent Development
7.3 Vectura Groupplc
7.3.1 Vectura Groupplc Company Information
7.3.2 Vectura Groupplc Introduction and Business Overview
7.3.3 Vectura Groupplc Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Vectura Groupplc Nasal Administration Product Offerings
7.3.5 Vectura Groupplc Recent Development
7.4 3M
7.4.1 3M Company Information
7.4.2 3M Introduction and Business Overview
7.4.3 3M Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.4.4 3M Nasal Administration Product Offerings
7.4.5 3M Recent Development
7.5 H&T Presspart Manufacturing Ltd.
7.5.1 H&T Presspart Manufacturing Ltd. Company Information
7.5.2 H&T Presspart Manufacturing Ltd. Introduction and Business Overview
7.5.3 H&T Presspart Manufacturing Ltd. Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.5.4 H&T Presspart Manufacturing Ltd. Nasal Administration Product Offerings
7.5.5 H&T Presspart Manufacturing Ltd. Recent Development
7.6 Nemera
7.6.1 Nemera Company Information
7.6.2 Nemera Introduction and Business Overview
7.6.3 Nemera Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Nemera Nasal Administration Product Offerings
7.6.5 Nemera Recent Development
7.7 GOFIRE INC.
7.7.1 GOFIRE INC. Company Information
7.7.2 GOFIRE INC. Introduction and Business Overview
7.7.3 GOFIRE INC. Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.7.4 GOFIRE INC. Nasal Administration Product Offerings
7.7.5 GOFIRE INC. Recent Development
7.8 Teva Pharmaceutical Industries Lto.
7.8.1 Teva Pharmaceutical Industries Lto. Company Information
7.8.2 Teva Pharmaceutical Industries Lto. Introduction and Business Overview
7.8.3 Teva Pharmaceutical Industries Lto. Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Teva Pharmaceutical Industries Lto. Nasal Administration Product Offerings
7.8.5 Teva Pharmaceutical Industries Lto. Recent Development
7.9 Recipharm
7.9.1 Recipharm Company Information
7.9.2 Recipharm Introduction and Business Overview
7.9.3 Recipharm Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Recipharm Nasal Administration Product Offerings
7.9.5 Recipharm Recent Development
7.10 Aptar
7.10.1 Aptar Company Information
7.10.2 Aptar Introduction and Business Overview
7.10.3 Aptar Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Aptar Nasal Administration Product Offerings
7.10.5 Aptar Recent Development
7.11 Catalent
7.11.1 Catalent Company Information
7.11.2 Catalent Introduction and Business Overview
7.11.3 Catalent Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Catalent Nasal Administration Product Offerings
7.11.5 Catalent Recent Development
7.12 Intertek
7.12.1 Intertek Company Information
7.12.2 Intertek Introduction and Business Overview
7.12.3 Intertek Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Intertek Nasal Administration Product Offerings
7.12.5 Intertek Recent Development
7.13 MedPharm
7.13.1 MedPharm Company Information
7.13.2 MedPharm Introduction and Business Overview
7.13.3 MedPharm Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.13.4 MedPharm Nasal Administration Product Offerings
7.13.5 MedPharm Recent Development
7.14 ONdrugDelivery
7.14.1 ONdrugDelivery Company Information
7.14.2 ONdrugDelivery Introduction and Business Overview
7.14.3 ONdrugDelivery Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.14.4 ONdrugDelivery Nasal Administration Product Offerings
7.14.5 ONdrugDelivery Recent Development
7.15 Optinose
7.15.1 Optinose Company Information
7.15.2 Optinose Introduction and Business Overview
7.15.3 Optinose Nasal Administration Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Optinose Nasal Administration Product Offerings
7.15.5 Optinose Recent Development
8 Industry Chain Analysis
8.1 Nasal Administration Industrial Chain
8.2 Nasal Administration Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nasal Administration Sales Model
8.5.2 Sales Channel
8.5.3 Nasal Administration Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Nasal Administration Market Trends
    Table 2. Nasal Administration Market Drivers & Opportunity
    Table 3. Nasal Administration Market Challenges
    Table 4. Nasal Administration Market Restraints
    Table 5. Global Nasal Administration Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Nasal Administration Revenue Market Share by Company (2019-2024)
    Table 7. Global Nasal Administration Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Nasal Administration Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Nasal Administration Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Nasal Administration Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Nasal Administration Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Nasal Administration
    Table 13. Global Nasal Administration Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Administration as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Nasal Administration Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Nasal Administration Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Nasal Administration Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Nasal Administration Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Nasal Administration Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Nasal Administration Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Nasal Administration Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Nasal Administration Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Nasal Administration Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Nasal Administration Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Nasal Administration Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Nasal Administration Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Nasal Administration Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Nasal Administration Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Nasal Administration Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Nasal Administration Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Nasal Administration Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Nasal Administration Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Nasal Administration Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Nasal Administration Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Nasal Administration Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Nasal Administration Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Nasal Administration Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Nasal Administration Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Nasal Administration Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Nasal Administration Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Nasal Administration Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Nasal Administration Sales Value by Region (2019-2024) & (%)
    Table 44. Global Nasal Administration Sales Value by Region (2025-2030) & (%)
    Table 45. Global Nasal Administration Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Nasal Administration Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Nasal Administration Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Nasal Administration Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Nasal Administration Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Nasal Administration Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Nasal Administration Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Nasal Administration Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Nasal Administration Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Nasal Administration Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Nasal Administration Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Nasal Administration Sales Volume, (2025-2030) & (K Units)
    Table 57. Consort Medicalplc. Company Information
    Table 58. Consort Medicalplc. Introduction and Business Overview
    Table 59. Consort Medicalplc. Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Consort Medicalplc. Nasal Administration Product Offerings
    Table 61. Consort Medicalplc. Recent Development
    Table 62. AptarGroup,Inc. Company Information
    Table 63. AptarGroup,Inc. Introduction and Business Overview
    Table 64. AptarGroup,Inc. Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. AptarGroup,Inc. Nasal Administration Product Offerings
    Table 66. AptarGroup,Inc. Recent Development
    Table 67. Vectura Groupplc Company Information
    Table 68. Vectura Groupplc Introduction and Business Overview
    Table 69. Vectura Groupplc Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Vectura Groupplc Nasal Administration Product Offerings
    Table 71. Vectura Groupplc Recent Development
    Table 72. 3M Company Information
    Table 73. 3M Introduction and Business Overview
    Table 74. 3M Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. 3M Nasal Administration Product Offerings
    Table 76. 3M Recent Development
    Table 77. H&T Presspart Manufacturing Ltd. Company Information
    Table 78. H&T Presspart Manufacturing Ltd. Introduction and Business Overview
    Table 79. H&T Presspart Manufacturing Ltd. Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. H&T Presspart Manufacturing Ltd. Nasal Administration Product Offerings
    Table 81. H&T Presspart Manufacturing Ltd. Recent Development
    Table 82. Nemera Company Information
    Table 83. Nemera Introduction and Business Overview
    Table 84. Nemera Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Nemera Nasal Administration Product Offerings
    Table 86. Nemera Recent Development
    Table 87. GOFIRE INC. Company Information
    Table 88. GOFIRE INC. Introduction and Business Overview
    Table 89. GOFIRE INC. Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. GOFIRE INC. Nasal Administration Product Offerings
    Table 91. GOFIRE INC. Recent Development
    Table 92. Teva Pharmaceutical Industries Lto. Company Information
    Table 93. Teva Pharmaceutical Industries Lto. Introduction and Business Overview
    Table 94. Teva Pharmaceutical Industries Lto. Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Teva Pharmaceutical Industries Lto. Nasal Administration Product Offerings
    Table 96. Teva Pharmaceutical Industries Lto. Recent Development
    Table 97. Recipharm Company Information
    Table 98. Recipharm Introduction and Business Overview
    Table 99. Recipharm Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Recipharm Nasal Administration Product Offerings
    Table 101. Recipharm Recent Development
    Table 102. Aptar Company Information
    Table 103. Aptar Introduction and Business Overview
    Table 104. Aptar Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Aptar Nasal Administration Product Offerings
    Table 106. Aptar Recent Development
    Table 107. Catalent Company Information
    Table 108. Catalent Introduction and Business Overview
    Table 109. Catalent Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Catalent Nasal Administration Product Offerings
    Table 111. Catalent Recent Development
    Table 112. Intertek Company Information
    Table 113. Intertek Introduction and Business Overview
    Table 114. Intertek Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Intertek Nasal Administration Product Offerings
    Table 116. Intertek Recent Development
    Table 117. MedPharm Company Information
    Table 118. MedPharm Introduction and Business Overview
    Table 119. MedPharm Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. MedPharm Nasal Administration Product Offerings
    Table 121. MedPharm Recent Development
    Table 122. ONdrugDelivery Company Information
    Table 123. ONdrugDelivery Introduction and Business Overview
    Table 124. ONdrugDelivery Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. ONdrugDelivery Nasal Administration Product Offerings
    Table 126. ONdrugDelivery Recent Development
    Table 127. Optinose Company Information
    Table 128. Optinose Introduction and Business Overview
    Table 129. Optinose Nasal Administration Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Optinose Nasal Administration Product Offerings
    Table 131. Optinose Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Nasal Administration Downstream Customers
    Table 135. Nasal Administration Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nasal Administration Product Picture
    Figure 2. Global Nasal Administration Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Nasal Administration Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Nasal Administration Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Nasal Administration Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Nasal Administration Report Years Considered
    Figure 7. Global Nasal Administration Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Nasal Administration Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nasal Administration Revenue in 2023
    Figure 10. Nasal Administration Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Dry Powder Inhaler Picture
    Figure 12. Metered Dose Inhaler Picture
    Figure 13. Atomizer Picture
    Figure 14. Global Nasal Administration Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Nasal Administration Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Nasal Administration Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Nasal Administration Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Nasal Administration Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Hospital
    Figure 20. Product Picture of Clinic
    Figure 21. Global Nasal Administration Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Nasal Administration Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Nasal Administration Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Nasal Administration Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Nasal Administration Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Nasal Administration Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Nasal Administration Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Nasal Administration Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Nasal Administration Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Nasal Administration Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Nasal Administration Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Nasal Administration Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Nasal Administration Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Nasal Administration Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Nasal Administration Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Nasal Administration Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Nasal Administration Sales Volume (%), (2019-2030)
    Figure 38. United States Nasal Administration Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Nasal Administration Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Nasal Administration Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Nasal Administration Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Nasal Administration Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Nasal Administration Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Nasal Administration Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Nasal Administration Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Nasal Administration Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Nasal Administration Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Nasal Administration Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Nasal Administration Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Nasal Administration Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Nasal Administration Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Nasal Administration Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Nasal Administration Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Nasal Administration Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Nasal Administration Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Nasal Administration Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Nasal Administration Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Nasal Administration Sales Value by Application (%), 2023 VS 2030
    Figure 59. Nasal Administration Industrial Chain
    Figure 60. Nasal Administration Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS